MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.230
0.00 (0.00%)
At close: Dec 30, 2024, 4:00 PM
3.240
+0.010 (0.31%)
After-hours: Dec 30, 2024, 4:52 PM EST
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $202.73 million as of December 30, 2024. Its market cap has decreased by -64.36% in one year.
Market Cap
202.73M
Enterprise Value
36.46M
1-Year Change
-64.36%
Ranking
Category
Stock Price
$3.23
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $202.73M, a decrease of -66.23%. That is a compound annual growth rate of -9.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 202.70M | -66.03% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.19B |
| UnitedHealth Group | 469.34B |
| Novo Nordisk | 393.39B |
| Johnson & Johnson | 349.23B |
| AbbVie | 314.57B |
| Merck & Co. | 252.20B |
| AstraZeneca | 204.17B |
| Thermo Fisher Scientific | 201.22B |